Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.70%
#2 Audiera Audiera +5.15%
#3 Wiki Cat Wiki Cat +3.90%
#4 Wibx Wibx +3.22%
#5 Quack AI Quack AI +2.73%
#6 TronBank TronBank +2.46%
#7 Status Status +2.14%
#8 Starpower Starpower +2.06%
#9 Janction Janction +1.95%
#10 Tutorial Tutorial +1.90%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Lisata Therapeutics, Inc. Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTA
Rank in Stocks #32451
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on... Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
Share Price
$1.11
Market Cap
$10.06M
Change (1 day)
1.38%
Change (1 year)
-56.32%
Country
US
Trade Lisata Therapeutics, Inc. (LSTA)

Category

Healthcare
Stock price history for Lisata Therapeutics, Inc. (LSTA)
Highest end of day price: $1.12 on 2026-08-01

Lowest end of day price: $188.93K on 1999-03-01
Stock price history of Lisata Therapeutics, Inc. from 1999 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 52.31%
2025 -28.03%
2024 3.05%
2023 -6.25%
2022 -78.23%
2021 -42.33%
2020 -36.52%
2019 -44.38%
2018 26.19%
2017 2.72%
2016 -70.04%
2015 -68.59%
2014 -44.74%
2013 2.99%
2012 11.54%
2011 -61.50%
2010 -9.12%
2009 147.46%
2008 -61.79%
2007 -75.15%
2006 19.82%
2005 -7.65%
2004 -69.11%
2003 253.51%
2002 -86.70%
2001 -26.92%
2000 -63.97%
1999 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.01%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 12.02%
BE